Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 79.03% | 67.10% | 67.24% | -182.68% | -65.57% |
| Total Depreciation and Amortization | -23.45% | -20.00% | -14.65% | -17.16% | -12.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.49% | 15.27% | 6.37% | 1,283.41% | 296.36% |
| Change in Net Operating Assets | -69.70% | -77.94% | -111.89% | 122.50% | -76.84% |
| Cash from Operations | 92.43% | 112.50% | 76.84% | 93.54% | -290.25% |
| Capital Expenditure | -600.00% | 100.00% | 50.00% | 83.33% | 94.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -1,633.33% | 33.33% | 62.50% | 91.67% |
| Cash from Investing | -100.00% | -67.86% | 40.00% | 99.50% | 93.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.57% | 94.72% | 76.59% | 96.51% | -304.07% |
